| Appendix Table: Prevalence of Chlamydia, Gonorrhea, Syphilis, and Trichomoniasis Among Various Populations of Women, 1974–1993 | |||||||
| % of Women Diagnosed With | |||||||
|---|---|---|---|---|---|---|---|
| Region/ Country |
Date | Ref. No. |
Population | Chla- mydia |
Gonor- rhea |
Syphillis | Trichomo- niasis |
| AFRICA | |||||||
| Burkina Faso | 1990–91 | 6,346 | 290 pregnant women | 0.3 | 2a | ||
| Cameroon | 1989–91 | 6,346 | 2,445 pregnant women | 13a | |||
| 1980b | 205 | 296 peripartum women | 10 | ||||
| 1977 | 91 | 296 pregnant women | 14 | ||||
| Cape Verde | 1983 | 277 | 316 pregnant women | 4c | |||
| Ethiopia | 1974–75 | 222 | 2,717 pregnant women | 17d | |||
| Gabon | 1982–85 | 188 | 623 pregnant women | 14d | |||
| 1980–82 | 331 | 530 pregnant women | 6 | ||||
| 1988b | 165 | 598 postpartum women | 10 | ||||
| Ghana | 1985b | 25 | 162 women attending a gynecological clinic | ||||
| Kenya | 1981b | 174 | 15,649 pregnant urban women | 1e | |||
| 1984–86 | 276 | 1,725 IUD acceptors | 12 | 4 | |||
| 1984 | 232 | 1,013 urban women in labor | 21 | 7 | |||
| 1984 | 153 | 728 peripartum women | 7 | ||||
| 1984b | 174 | 200 pregnant urban women | 5 | ||||
| 1987 | 174 | 402 pregnant urban women | 1 | ||||
| Mozambique | 1982–83 | 167 | 1,468 pregnant women | 2–10d | |||
| Nigeria | 1986–89 | 143 | 2,224 women having cervical cytology tests | 3 | |||
| Swaziland | 1986 | 108 | 283 pregnant women | 13c | |||
| Tanzania | 1978 | 176 | 405 family planning clients | 7 | |||
| 1983–84 | 58 | 5,430 pregnant women | 16c | ||||
| 1992 | 6 | 259 pregnant women | 5e | ||||
| Uganda | 1980b | 14 | 295 women in low-fertility area | 18 | |||
| Zaire | 1993b | 164 | 1,103 pregnant women | 1e | 18 | ||
| Zambia | 1982b | 247 | 202 pregnant women | 13d | |||
| 1983 | 117 | 1,437 pregnant women | 13c | ||||
| Zimbabwe | 1986–87b | 180 | 188 pregnant women | 9 | |||
| 1986–87 | 180 | 214 women in labor | 7 | 19 | |||
| 1983b | 181 | 199 pregnant women | 0 | 31 | |||
| 1979–80 | 161 | 18,470 pregnant women | 0.5c | ||||
| ASIA & PACIFIC | |||||||
| China | 1986 | 120 | 1,000 family planning clients or gynecologic outpatients | 1 | |||
| Fiji | 1985–86 | 110 | 244 pregnant women | 45 | |||
| 440 pregnant women | 2 | 9d | |||||
| India | 1986 | 18 | 650 village women | 0.3 | |||
| 558 ever-married women | 14 | ||||||
| 1988–89 | 18 | 115 pregnant women in Bombay | 5c | ||||
| Indonesia | 1987b | 311 | 1,503 women in cervical cytology screening campaign in Bali | 8 | |||
| 11,240 women in cervical cytology screening campaign in Surabaya | 30 | ||||||
| LATIN AMERICA & CARIBBEAN | |||||||
| Brazil | 1984b | 41 | 41 gynecology patients | 24 | |||
| Chile | 1983 | 193 | 29,501 asymptomatic women undergoing cervical cytology screening | 11 | |||
| 1984b | 71 | 256 pregnant women | 2 | ||||
| 1984b | 27 | 394 asymptomatic gynecology patients | 5 | ||||
| Eastern Caribbean | 1990 | 6,346 | 160 pregnant women | 13 | |||
| Guatemala | 1992 | 6,346 | 303 family planning clients | 7 | 0.3 | 0.3c | 7 |
| 301 pregnant women | 5 | 1 | 0.3c | 10 | |||
| Nicaragua | 1993b | 80 | 636 antenatal or family planning clients | 4 | 1 | 8 | |
| NEAR EAST | |||||||
| Saudi Arabia | 1989b | 17 | 106 pregnant women | 9 | |||
| 1986b | 124 | 4,361 pregnant women | <1d | ||||
| Tunisia | 1993b | 24 | 1,030 pregnant women | 3 | 0.5e | ||
| DEVELOPED COUNTRIES | |||||||
| Canada | 1988b | 30 | 520 women seek abortion | 11 | |||
| New Zealand | 1984–85 | 16 | 2,034 family planning clients | 18 | |||
| United States | 1985–87 | 87 | 7,879 women attending a health clinic for adolescents | 6-8 | |||
| 1986 | 98 | 2,761 family planning clients | 11 | ||||
| 1991 | 305 | 5.2 million women participating in targeted screening programs | 2 | ||||
| 1987 | 204 | 4,920 urban women in labor | 0.02f | ||||
| 1991b | 62 | 13,816 pregnant women | 13 | ||||
| aBoth rapid plasma reagin (RPR) test and Treponema pallidum hemagglutination assay (TPHA) positive. bYear of publication (year of study not specified) cRapid plasma reagin (RPR) or Venereal Disease REsearch Laboratory (VDRL) test positive dTPHA or fluorescent treponemal antibody-absorption (FTA-ABS) test positive eTest not specified fRPR and FTA-ABS tests positive | |||||||